Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Pao

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Monitoring EGFR-mutant lung cancers by means of the bloodWilliam Pao
Cancer Chemotherapy and Pharmacology|November 10, 2006
Defining clinically relevant molecular subsets of lung cancerWilliam Pao
Proceedings of the American Thoracic Society|May 3, 2012
New approaches to targeted therapy in lung cancerWilliam Pao
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2010
Highly active antitumor therapy (HAATT) for epidermal growth factor receptor-mutant lung cancerJuliann Chmielecki, William Pao
The Lancet. Oncology|February 1, 2011
New driver mutations in non-small-cell lung cancerWilliam Pao, Nicolas Girard
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal methodWilliam Pao, Marc Ladanyi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
EML4-ALK: honing in on a new target in non-small-cell lung cancerLeora Horn, William Pao
Current Topics in Microbiology and Immunology|August 26, 2011
EGFR mutant lung cancerYixuan Gong, William Pao
Nature Reviews. Cancer|October 23, 2010
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancerWilliam Pao, Juliann Chmielecki
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2008
Lung adenocarcinoma: guiding EGFR-targeted therapy and beyondMarc Ladanyi, William Pao
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Monitoring EGFR-mutant lung cancers by means of the bloodWilliam Pao
Cancer Chemotherapy and Pharmacology|November 10, 2006
Defining clinically relevant molecular subsets of lung cancerWilliam Pao
Proceedings of the American Thoracic Society|May 3, 2012
New approaches to targeted therapy in lung cancerWilliam Pao
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 11, 2010
Highly active antitumor therapy (HAATT) for epidermal growth factor receptor-mutant lung cancerJuliann Chmielecki, William Pao
The Lancet. Oncology|February 1, 2011
New driver mutations in non-small-cell lung cancerWilliam Pao, Nicolas Girard
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 6, 2007
Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal methodWilliam Pao, Marc Ladanyi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
EML4-ALK: honing in on a new target in non-small-cell lung cancerLeora Horn, William Pao
Current Topics in Microbiology and Immunology|August 26, 2011
EGFR mutant lung cancerYixuan Gong, William Pao
Nature Reviews. Cancer|October 23, 2010
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancerWilliam Pao, Juliann Chmielecki
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 24, 2008
Lung adenocarcinoma: guiding EGFR-targeted therapy and beyondMarc Ladanyi, William Pao
Pageof 21